| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L-ascorbic acid transmembrane transporter activity | 2.81e-06 | 2 | 34 | 2 | GO:0015229 | |
| GeneOntologyMolecularFunction | L-ascorbate:sodium symporter activity | 2.81e-06 | 2 | 34 | 2 | GO:0008520 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.97e-04 | 171 | 34 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | GTPase activity | 2.61e-04 | 341 | 34 | 5 | GO:0003924 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.78e-04 | 775 | 34 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | collagen binding | 3.51e-04 | 81 | 34 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.51e-04 | 81 | 34 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 3.77e-04 | 17 | 34 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 4.49e-04 | 839 | 34 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 4.52e-04 | 840 | 34 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.52e-04 | 840 | 34 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | GTP binding | 5.24e-04 | 397 | 34 | 5 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 8.26e-04 | 439 | 34 | 5 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 8.26e-04 | 439 | 34 | 5 | GO:0019001 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 9.62e-04 | 27 | 34 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.08e-03 | 119 | 34 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.11e-03 | 29 | 34 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.55e-03 | 296 | 34 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.62e-03 | 35 | 34 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.64e-03 | 301 | 34 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 1.71e-03 | 36 | 34 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | symporter activity | 2.10e-03 | 150 | 34 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.32e-03 | 42 | 34 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 6.86e-03 | 73 | 34 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.75e-03 | 465 | 34 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 8.46e-03 | 477 | 34 | 4 | GO:0022804 | |
| GeneOntologyBiologicalProcess | 'de novo' UMP biosynthetic process | 7.90e-06 | 3 | 34 | 2 | GO:0044205 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid transmembrane transport | 7.90e-06 | 3 | 34 | 2 | GO:0015882 | |
| GeneOntologyBiologicalProcess | UDP biosynthetic process | 1.58e-05 | 4 | 34 | 2 | GO:0006225 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside diphosphate biosynthetic process | 1.58e-05 | 4 | 34 | 2 | GO:0009194 | |
| GeneOntologyBiologicalProcess | 'de novo' pyrimidine nucleobase biosynthetic process | 3.94e-05 | 6 | 34 | 2 | GO:0006207 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside diphosphate biosynthetic process | 3.94e-05 | 6 | 34 | 2 | GO:0009139 | |
| GeneOntologyBiologicalProcess | UDP metabolic process | 5.51e-05 | 7 | 34 | 2 | GO:0046048 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside diphosphate metabolic process | 5.51e-05 | 7 | 34 | 2 | GO:0009193 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase biosynthetic process | 7.34e-05 | 8 | 34 | 2 | GO:0019856 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside diphosphate metabolic process | 9.43e-05 | 9 | 34 | 2 | GO:0009138 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate biosynthetic process | 1.18e-04 | 10 | 34 | 2 | GO:0009188 | |
| GeneOntologyBiologicalProcess | UMP biosynthetic process | 1.44e-04 | 11 | 34 | 2 | GO:0006222 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate biosynthetic process | 1.72e-04 | 12 | 34 | 2 | GO:0009174 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate biosynthetic process | 2.03e-04 | 13 | 34 | 2 | GO:0009133 | |
| GeneOntologyBiologicalProcess | UMP metabolic process | 3.12e-04 | 16 | 34 | 2 | GO:0046049 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 3.12e-04 | 16 | 34 | 2 | GO:0019852 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate metabolic process | 3.53e-04 | 17 | 34 | 2 | GO:0009173 | |
| GeneOntologyBiologicalProcess | nucleobase biosynthetic process | 3.97e-04 | 18 | 34 | 2 | GO:0046112 | |
| GeneOntologyBiologicalProcess | lactone metabolic process | 4.43e-04 | 19 | 34 | 2 | GO:1901334 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate biosynthetic process | 4.43e-04 | 19 | 34 | 2 | GO:0009130 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 5.97e-04 | 22 | 34 | 2 | GO:0006206 | |
| GeneOntologyBiologicalProcess | vitamin transmembrane transport | 6.53e-04 | 23 | 34 | 2 | GO:0035461 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 7.73e-04 | 25 | 34 | 2 | GO:0009220 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate metabolic process | 8.36e-04 | 26 | 34 | 2 | GO:0009129 | |
| GeneOntologyBiologicalProcess | body fluid secretion | 1.03e-03 | 121 | 34 | 3 | GO:0007589 | |
| MousePheno | abnormal vitamin C level | 5.90e-05 | 7 | 24 | 2 | MP:0011229 | |
| Domain | Xan_ur_permease | 9.64e-06 | 3 | 34 | 2 | PF00860 | |
| Domain | Xant/urac/vitC | 9.64e-06 | 3 | 34 | 2 | IPR006043 | |
| Domain | - | 3.30e-04 | 746 | 34 | 7 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 7.12e-04 | 848 | 34 | 7 | IPR027417 | |
| Domain | Small_GTP-bd_dom | 3.43e-03 | 167 | 34 | 3 | IPR005225 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 1.14e-04 | 8 | 29 | 2 | M27091 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 1.46e-04 | 9 | 29 | 2 | MM14769 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.22e-04 | 11 | 29 | 2 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.66e-04 | 12 | 29 | 2 | MM1526 | |
| Pathway | REACTOME_NUCLEOTIDE_BIOSYNTHESIS | 3.66e-04 | 14 | 29 | 2 | M27830 | |
| Pathway | REACTOME_NUCLEOTIDE_BIOSYNTHESIS | 3.66e-04 | 14 | 29 | 2 | MM15551 | |
| Pubmed | 3.86e-07 | 725 | 34 | 8 | 27025967 | ||
| Pubmed | 4.64e-07 | 64 | 34 | 4 | 22865885 | ||
| Pubmed | 6.90e-07 | 18 | 34 | 3 | 19116923 | ||
| Pubmed | 6.90e-07 | 18 | 34 | 3 | 19143821 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19216494 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18845575 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22348976 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10556521 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19243932 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34599650 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17664139 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15890648 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10395795 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10471399 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21733302 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23837633 | ||
| Pubmed | N-Glycosylation is required for Na+-dependent vitamin C transporter functionality. | 9.28e-07 | 2 | 34 | 2 | 18619416 | |
| Pubmed | Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. | 9.28e-07 | 2 | 34 | 2 | 15993839 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18791929 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28177761 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23613229 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16357110 | ||
| Pubmed | Vitamin C transporter gene polymorphisms, dietary vitamin C and serum ascorbic acid. | 9.28e-07 | 2 | 34 | 2 | 20588054 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24815519 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18247577 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18417304 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20471816 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 27932501 | ||
| Pubmed | Gender and sodium-ascorbate transporter isoforms determine ascorbate concentrations in mice. | 9.28e-07 | 2 | 34 | 2 | 15333707 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11984580 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10631088 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11984597 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 34780525 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9804989 | ||
| Pubmed | A family of mammalian Na+-dependent L-ascorbic acid transporters. | 9.28e-07 | 2 | 34 | 2 | 10331392 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11396616 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 36310070 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 20122894 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 22692683 | ||
| Pubmed | Polymorphisms of CXCR3-binding chemokines in type 1 diabetes. | 5.56e-06 | 4 | 34 | 2 | 19410617 | |
| Pubmed | 5.77e-06 | 120 | 34 | 4 | 27320910 | ||
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 5.77e-06 | 120 | 34 | 4 | 37929963 | |
| Pubmed | 9.26e-06 | 5 | 34 | 2 | 22990596 | ||
| Pubmed | 1.39e-05 | 6 | 34 | 2 | 18668520 | ||
| Pubmed | 1.62e-05 | 50 | 34 | 3 | 23703321 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 1.64e-05 | 565 | 34 | 6 | 33567341 | |
| Pubmed | 1.94e-05 | 7 | 34 | 2 | 33549889 | ||
| Pubmed | 4.47e-05 | 202 | 34 | 4 | 24639526 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 6.31e-05 | 1455 | 34 | 8 | 22863883 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 7.70e-05 | 84 | 34 | 3 | 25670202 | |
| Pubmed | 8.26e-05 | 86 | 34 | 3 | 25044020 | ||
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 9.46e-05 | 90 | 34 | 3 | 30699358 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 9.52e-05 | 477 | 34 | 5 | 31300519 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.12e-04 | 256 | 34 | 4 | 35777956 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.18e-04 | 807 | 34 | 6 | 30575818 | |
| Pubmed | Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects. | 1.25e-04 | 17 | 34 | 2 | 23028341 | |
| Pubmed | CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1. | 1.33e-04 | 101 | 34 | 3 | 34462429 | |
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 1.33e-04 | 101 | 34 | 3 | 20587610 | |
| Pubmed | 1.41e-04 | 18 | 34 | 2 | 18987644 | ||
| Pubmed | 1.61e-04 | 534 | 34 | 5 | 35032548 | ||
| Pubmed | 1.86e-04 | 113 | 34 | 3 | 30352685 | ||
| Pubmed | 1.93e-04 | 21 | 34 | 2 | 21408207 | ||
| Pubmed | 2.12e-04 | 22 | 34 | 2 | 27527664 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 2.20e-04 | 571 | 34 | 5 | 37167062 | |
| Pubmed | 2.33e-04 | 122 | 34 | 3 | 36929488 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 2.45e-04 | 1321 | 34 | 7 | 27173435 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.84e-04 | 1353 | 34 | 7 | 29467282 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 3.02e-04 | 1367 | 34 | 7 | 32687490 | |
| Pubmed | 3.63e-04 | 142 | 34 | 3 | 30809309 | ||
| Pubmed | 3.66e-04 | 638 | 34 | 5 | 33239621 | ||
| Pubmed | 3.70e-04 | 29 | 34 | 2 | 21829377 | ||
| Pubmed | 4.14e-04 | 1440 | 34 | 7 | 30833792 | ||
| Pubmed | 4.73e-04 | 374 | 34 | 4 | 23824909 | ||
| Pubmed | Expression of genes involved in mammalian meiosis during the transition from egg to embryo. | 4.81e-04 | 33 | 34 | 2 | 11389549 | |
| Pubmed | 5.02e-04 | 1487 | 34 | 7 | 33957083 | ||
| Pubmed | Diversification of stem cell molecular repertoire by alternative splicing. | 5.41e-04 | 35 | 34 | 2 | 16183747 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 5.73e-04 | 166 | 34 | 3 | 35687106 | |
| Pubmed | 5.73e-04 | 166 | 34 | 3 | 34687317 | ||
| Pubmed | 6.35e-04 | 172 | 34 | 3 | 27375898 | ||
| Pubmed | 6.68e-04 | 175 | 34 | 3 | 19851445 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 7.02e-04 | 178 | 34 | 3 | 27637333 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 7.13e-04 | 179 | 34 | 3 | 36261009 | |
| Pubmed | 7.23e-04 | 419 | 34 | 4 | 15635413 | ||
| Pubmed | 7.43e-04 | 41 | 34 | 2 | 8590280 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 7.81e-04 | 1149 | 34 | 6 | 35446349 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 7.97e-04 | 430 | 34 | 4 | 38172120 | |
| Pubmed | 8.50e-04 | 1168 | 34 | 6 | 19946888 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.68e-04 | 440 | 34 | 4 | 34244565 | |
| Pubmed | 8.75e-04 | 441 | 34 | 4 | 31239290 | ||
| Pubmed | 9.41e-04 | 197 | 34 | 3 | 31620119 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 9.75e-04 | 454 | 34 | 4 | 33226137 | |
| Interaction | PHB1 interactions | 1.06e-05 | 1123 | 34 | 10 | int:PHB1 | |
| Cytoband | 6p21.3 | 8.43e-04 | 250 | 34 | 3 | 6p21.3 | |
| Cytoband | 20q13.33 | 1.58e-03 | 79 | 34 | 2 | 20q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 2.30e-03 | 355 | 34 | 3 | chr8q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 5.48e-03 | 149 | 34 | 2 | chr2p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 6.08e-03 | 503 | 34 | 3 | chr6p21 | |
| Coexpression | MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP | 7.30e-05 | 10 | 34 | 2 | M41165 | |
| Coexpression | MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP | 7.30e-05 | 10 | 34 | 2 | M41004 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 9.44e-05 | 185 | 34 | 4 | M8792 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 9.84e-05 | 187 | 34 | 4 | M6807 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | 1.16e-04 | 195 | 34 | 4 | M6899 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.26e-04 | 13 | 34 | 2 | M1888 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP | 1.28e-04 | 200 | 34 | 4 | M6418 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 1.28e-04 | 200 | 34 | 4 | M5926 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD8_TCELL_DN | 1.28e-04 | 200 | 34 | 4 | M4777 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP | 1.28e-04 | 200 | 34 | 4 | M4332 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 1.31e-04 | 76 | 34 | 3 | M4551 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-06 | 161 | 34 | 4 | 5cb91ae9674b370a27be0d5852c3816b4434239e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-06 | 161 | 34 | 4 | 0e2b54a63781397f6b99eb0e201fbb820cbd7cc6 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 178 | 34 | 4 | 6bad4439a1692332f70135ff446a1048fa4c399d | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 178 | 34 | 4 | 3f6feb4ed7779cf5684f52939350b41d7718c3c6 | |
| ToppCell | moderate-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.12e-05 | 183 | 34 | 4 | 4ba879552e2101a341f3224826d364ac64c72260 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.27e-05 | 189 | 34 | 4 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-05 | 189 | 34 | 4 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-05 | 189 | 34 | 4 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 97772e69e6f51ebffbb5433ca7b40f1048723220 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 72c2b824acdc43139e6635785df3ed3feb58ec46 | |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 190 | 34 | 4 | 0b7200897b2c389632c9b1ee37e272b811555dbc | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 191 | 34 | 4 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.35e-05 | 192 | 34 | 4 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 192 | 34 | 4 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 193 | 34 | 4 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 193 | 34 | 4 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 34 | 4 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 34 | 4 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 34 | 4 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 194 | 34 | 4 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 195 | 34 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 195 | 34 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 195 | 34 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 198 | 34 | 4 | c58e2d3a21fcca9f1accccc5303ca4222b6c8432 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 198 | 34 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 198 | 34 | 4 | f4ff9520598ebc52b3a1f31eee766957983e16b4 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 199 | 34 | 4 | 946d904a880c0e211861fcec7e120853ffade282 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.55e-05 | 199 | 34 | 4 | 2ac716f887687b5109fb9feced75d5c62646a268 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.55e-05 | 199 | 34 | 4 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.55e-05 | 199 | 34 | 4 | aa6f1390283617c7f9aaf91d379024832ea24a9e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 200 | 34 | 4 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-05 | 83 | 34 | 3 | 7893ce9fbf34c6250dca9c265fe9b2d4cb889ade | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Cd74|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.19e-05 | 115 | 34 | 3 | 4c7d78a246f1b44846fb959359515ef185530053 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 156 | 34 | 3 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| ToppCell | PBMC-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 2.35e-04 | 158 | 34 | 3 | 5fefab4831687cd8dd45f5cc84f681398069c3be | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-04 | 166 | 34 | 3 | 75d719617c61409860f298ce91cbe3a0aafa0553 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-04 | 166 | 34 | 3 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-04 | 167 | 34 | 3 | 589c0acfeb4d70931b6726fb3331d85a54e74d56 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 2.76e-04 | 167 | 34 | 3 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 2.76e-04 | 167 | 34 | 3 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-04 | 167 | 34 | 3 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 168 | 34 | 3 | 6dd58fd981750da49afd53796f244e1803cce97f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 169 | 34 | 3 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 2.91e-04 | 170 | 34 | 3 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | ILEUM-non-inflamed-(3)_mature_DC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.91e-04 | 170 | 34 | 3 | 60151394460e6f27a42fab434e8b7b2adc78b128 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.91e-04 | 170 | 34 | 3 | badbe200e9d5003d23d115955b10b4ea767f6c26 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 170 | 34 | 3 | 067657ca7fcf5a0ffbd168b5c4609a30ca508f22 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 170 | 34 | 3 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.96e-04 | 171 | 34 | 3 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 172 | 34 | 3 | ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 172 | 34 | 3 | 3fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 37825d0dda028cf677ff6ff16ea58bff75cb25a7 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 173 | 34 | 3 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | facs-Marrow-T-cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 806f94f5c3ac836ddffc389d3c2cd7e4da7a608d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 34 | 3 | 35dc897e06f905419d44093a92170d2cec35dd51 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-04 | 173 | 34 | 3 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.06e-04 | 173 | 34 | 3 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 173 | 34 | 3 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 174 | 34 | 3 | 4120656e6d6cf5435a248326b5fdbdc7b22137af | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 174 | 34 | 3 | ea27868d0373843a5137569ac3f9e3f8c92c7dcc | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-04 | 174 | 34 | 3 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 175 | 34 | 3 | eedb33e3e350169d1d37f2ac9939dcf704e7b696 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CXCL9+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.17e-04 | 175 | 34 | 3 | 48f5bdbfc1ba40c3fb6411f12a69e61da2138296 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-04 | 175 | 34 | 3 | 1c7725f917f3d6b9e0a31ede9524690f408a5ea1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.22e-04 | 176 | 34 | 3 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 176 | 34 | 3 | 8e4600efeea095a92178cfd26d7c58db7dfc0c80 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 177 | 34 | 3 | aa56129d2d5a73a10e33b7162233a4d9337ee535 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.27e-04 | 177 | 34 | 3 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.27e-04 | 177 | 34 | 3 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 177 | 34 | 3 | d78a6003ce2d15d7771ae385de252eec7e3c3eea | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.27e-04 | 177 | 34 | 3 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 177 | 34 | 3 | 70ca5b6fde2e38af1eb88a7d6e8746edba298191 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.33e-04 | 178 | 34 | 3 | fd2bdb4796e86c8cff2d25f0c730ffea21db8787 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.33e-04 | 178 | 34 | 3 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.38e-04 | 179 | 34 | 3 | ba64bfb757d6e3be631ee95abfa24b47861f6a14 | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.38e-04 | 179 | 34 | 3 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.38e-04 | 179 | 34 | 3 | 8bd85ee92791996377bcafed198c1bb3c9af4c3c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 179 | 34 | 3 | 68ccfe66474d049a926afc21bffa231446becc69 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-04 | 180 | 34 | 3 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 181 | 34 | 3 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-04 | 181 | 34 | 3 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 181 | 34 | 3 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-04 | 181 | 34 | 3 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-aDC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.50e-04 | 181 | 34 | 3 | 8f7e5c310f4cdc4b2fb54fea950d01e56bd298e1 | |
| ToppCell | Club-club-8|World / Class top | 3.55e-04 | 182 | 34 | 3 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-04 | 183 | 34 | 3 | 2dde2fb48e7d31271c2f6b1dd74b2ab0b2cb520c | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-04 | 183 | 34 | 3 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 183 | 34 | 3 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CXCL9+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.61e-04 | 183 | 34 | 3 | 99a36e9c74346b619b3b87d8d6bbf9b4b797c821 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-04 | 183 | 34 | 3 | 02deb595819fb864a934fd0fcaad684f1ca42964 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 183 | 34 | 3 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-04 | 184 | 34 | 3 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 184 | 34 | 3 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 185 | 34 | 3 | 655a9357a7711cefb48395e0b2a5a0ab90bcf3f5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 3.73e-04 | 185 | 34 | 3 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-04 | 185 | 34 | 3 | 60e223cd0ed3022e3f98ce6b766bedd14c534885 | |
| Drug | 6-deoxy-6-bromoascorbic acid | 2.16e-06 | 2 | 34 | 2 | ctd:C068572 | |
| Drug | o-CP | 5.47e-06 | 78 | 34 | 4 | CID000445454 | |
| Drug | AC1L8TCY | 8.68e-06 | 27 | 34 | 3 | CID000407798 | |
| Drug | cyanine | 1.93e-05 | 35 | 34 | 3 | CID000065043 | |
| Drug | Dicamba | 4.52e-05 | 7 | 34 | 2 | ctd:D003996 | |
| Drug | uracil | 4.66e-05 | 269 | 34 | 5 | CID000001174 | |
| Drug | p-aminohippurate | 7.57e-05 | 55 | 34 | 3 | CID000002148 | |
| Drug | menoctone | 7.74e-05 | 9 | 34 | 2 | CID000026738 | |
| Drug | dltp | 7.99e-05 | 56 | 34 | 3 | CID000031250 | |
| Drug | Trimethoprim | 1.18e-04 | 11 | 34 | 2 | ctd:D014295 | |
| Drug | glyoxylate | 1.34e-04 | 176 | 34 | 4 | CID000000760 | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; HL60; HT_HG-U133A | 1.55e-04 | 183 | 34 | 4 | 2710_UP | |
| Drug | butanetetracarboxylic acid | 1.67e-04 | 13 | 34 | 2 | CID000015560 | |
| Drug | 6-azauracil | 1.69e-04 | 72 | 34 | 3 | CID000068037 | |
| Drug | Toxaphene | 1.76e-04 | 73 | 34 | 3 | ctd:D014112 | |
| Drug | Od-T | 1.95e-04 | 14 | 34 | 2 | CID006102742 | |
| Drug | azaUMP | 1.95e-04 | 14 | 34 | 2 | CID000001856 | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4389_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 7140_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; HL60; HG-U133A | 2.14e-04 | 199 | 34 | 4 | 1727_UP | |
| Drug | carbamyl-L-aspartate | 2.56e-04 | 16 | 34 | 2 | CID000000279 | |
| Drug | o668 | 4.47e-04 | 21 | 34 | 2 | CID000004109 | |
| Drug | dihydroorotate | 5.37e-04 | 23 | 34 | 2 | CID000000648 | |
| Drug | crocin | 5.37e-04 | 23 | 34 | 2 | ctd:C029036 | |
| Drug | PMEI | 5.85e-04 | 24 | 34 | 2 | CID000451928 | |
| Drug | Corticosterone | 6.97e-04 | 272 | 34 | 4 | ctd:D003345 | |
| Drug | dimethyl phosphate | 7.42e-04 | 27 | 34 | 2 | CID000013134 | |
| Drug | propoxur | 7.99e-04 | 28 | 34 | 2 | CID000004944 | |
| Drug | abrine | 8.29e-04 | 285 | 34 | 4 | ctd:C496492 | |
| Drug | NSC25740 | 8.57e-04 | 29 | 34 | 2 | CID000230648 | |
| Drug | AC1LAHG0 | 9.17e-04 | 30 | 34 | 2 | CID000513869 | |
| Drug | Ranitidine | 9.56e-04 | 130 | 34 | 3 | ctd:D011899 | |
| Drug | aspartate | 9.64e-04 | 518 | 34 | 5 | CID000000424 | |
| Drug | orotidine | 9.80e-04 | 31 | 34 | 2 | CID000092751 | |
| Drug | anti-K | 1.11e-03 | 33 | 34 | 2 | CID000005337 | |
| Drug | 4-amino-2,6-dinitrotoluene | 1.17e-03 | 541 | 34 | 5 | ctd:C035207 | |
| Drug | AC1NDX9W | 1.25e-03 | 35 | 34 | 2 | CID004633087 | |
| Drug | OPC-31260 | 1.47e-03 | 38 | 34 | 2 | CID000119369 | |
| Drug | phosphorus anion | 1.47e-03 | 38 | 34 | 2 | CID009548888 | |
| Disease | orotic aciduria (implicated_via_orthology) | 1.29e-06 | 2 | 34 | 2 | DOID:0050833 (implicated_via_orthology) | |
| Disease | Congenital hypoplastic anemia | 1.29e-06 | 2 | 34 | 2 | C0949116 | |
| Disease | neuromyelitis optica | 3.86e-06 | 3 | 34 | 2 | EFO_0004256 | |
| Disease | X-24431 measurement | 3.86e-06 | 3 | 34 | 2 | EFO_0800882 | |
| Disease | AQP4-IgG-positive neuromyelitis optica | 7.72e-06 | 4 | 34 | 2 | EFO_0009584 | |
| Disease | Acute Erythroblastic Leukemia | 7.72e-06 | 4 | 34 | 2 | C0023440 | |
| Disease | tartronate (hydroxymalonate) measurement | 7.72e-06 | 4 | 34 | 2 | EFO_0800944 | |
| Disease | extraversion measurement | 1.93e-05 | 6 | 34 | 2 | EFO_0007913 | |
| Disease | glutamate receptor 4 measurement | 1.93e-05 | 6 | 34 | 2 | EFO_0801630 | |
| Disease | complement C4 measurement | 2.97e-05 | 52 | 34 | 3 | EFO_0004984 | |
| Disease | Hereditary spherocytosis | 3.59e-05 | 8 | 34 | 2 | C0037889 | |
| Disease | myasthenia gravis (is_implicated_in) | 3.59e-05 | 8 | 34 | 2 | DOID:437 (is_implicated_in) | |
| Disease | gdnf family receptor alpha-1 measurement | 3.59e-05 | 8 | 34 | 2 | EFO_0020400 | |
| Disease | susceptibility to childhood ear infection measurement | 4.41e-05 | 171 | 34 | 4 | EFO_0007904 | |
| Disease | threonate measurement | 5.77e-05 | 10 | 34 | 2 | EFO_0021032 | |
| Disease | Anemia, Sickle Cell | 5.77e-05 | 10 | 34 | 2 | C0002895 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 5.77e-05 | 10 | 34 | 2 | EFO_0022035 | |
| Disease | CCL19 measurement | 5.77e-05 | 10 | 34 | 2 | EFO_0009415 | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 7.04e-05 | 11 | 34 | 2 | EFO_0020224 | |
| Disease | Cooley's anemia | 8.44e-05 | 12 | 34 | 2 | C0002875 | |
| Disease | Thalassemia Minor | 8.44e-05 | 12 | 34 | 2 | C0085578 | |
| Disease | Thalassemia Intermedia | 8.44e-05 | 12 | 34 | 2 | C0271979 | |
| Disease | beta Thalassemia | 8.44e-05 | 12 | 34 | 2 | C0005283 | |
| Disease | susceptibility to shingles measurement | 1.12e-04 | 81 | 34 | 3 | EFO_0008401 | |
| Disease | ascorbic acid 3-sulfate measurement | 1.16e-04 | 14 | 34 | 2 | EFO_0800173 | |
| Disease | glycerate measurement | 1.34e-04 | 15 | 34 | 2 | EFO_0021029 | |
| Disease | Hemoglobin F Disease | 1.34e-04 | 15 | 34 | 2 | C0019025 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 1.53e-04 | 16 | 34 | 2 | EFO_0020346 | |
| Disease | vitamin C measurement | 1.53e-04 | 16 | 34 | 2 | EFO_0600003 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 2.93e-04 | 22 | 34 | 2 | EFO_0021881 | |
| Disease | coronary artery disease | 3.60e-04 | 1194 | 34 | 7 | EFO_0001645 | |
| Disease | complement C4b measurement | 3.80e-04 | 25 | 34 | 2 | EFO_0008092 | |
| Disease | docosapentaenoic acid measurement | 4.44e-04 | 27 | 34 | 2 | EFO_0006809 | |
| Disease | hair morphology | 5.13e-04 | 29 | 34 | 2 | EFO_0005038 | |
| Disease | right ventricular ejection fraction measurement | 5.49e-04 | 30 | 34 | 2 | EFO_0021816 | |
| Disease | oxalate measurement | 6.25e-04 | 32 | 34 | 2 | EFO_0010517 | |
| Disease | chronic hepatitis C virus infection | 6.65e-04 | 33 | 34 | 2 | EFO_0004220 | |
| Disease | urate measurement, bone density | 6.72e-04 | 619 | 34 | 5 | EFO_0003923, EFO_0004531 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.06e-04 | 34 | 34 | 2 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | right ventricular systolic volume measurement | 7.49e-04 | 35 | 34 | 2 | EFO_0021815 | |
| Disease | heart rate response to exercise | 1.13e-03 | 43 | 34 | 2 | EFO_0009184 | |
| Disease | triglycerides in large LDL measurement | 1.13e-03 | 43 | 34 | 2 | EFO_0022319 | |
| Disease | suicide behaviour measurement | 1.13e-03 | 43 | 34 | 2 | EFO_0006882 | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 1.24e-03 | 45 | 34 | 2 | EFO_0803319 | |
| Disease | total lipids in small LDL | 1.35e-03 | 47 | 34 | 2 | EFO_0022168 | |
| Disease | Celiac Disease | 1.35e-03 | 47 | 34 | 2 | C0007570 | |
| Disease | free cholesterol in medium VLDL measurement | 1.35e-03 | 47 | 34 | 2 | EFO_0022269 | |
| Disease | total lipids in lipoprotein particles measurement | 1.41e-03 | 48 | 34 | 2 | EFO_0022309 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 1.46e-03 | 49 | 34 | 2 | DOID:684 (implicated_via_orthology) | |
| Disease | retinal drusen | 1.59e-03 | 51 | 34 | 2 | EFO_1001155 | |
| Disease | phospholipids in medium VLDL measurement | 1.65e-03 | 52 | 34 | 2 | EFO_0022154 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTVRGGRLRGIRLKT | 41 | P22303 | |
| RCVRTVPVGGVVKSV | 446 | Q14137 | |
| VKGPLRVGAIVETRT | 56 | P29374 | |
| IARTIVLQEIVGKGR | 191 | Q8NER5 | |
| IVVGTVFIIRGLRSV | 231 | P01909 | |
| IAGIRGIQGVVRKTV | 166 | Q14156 | |
| GGVGSIVRVLTARKT | 136 | O15511 | |
| GLVGSRPVVTRVVIK | 121 | Q9HC84 | |
| VLRSVGAGVVVGKVR | 581 | Q9Y5H5 | |
| RVKGRTGLRVVVKAV | 1246 | Q8TEM1 | |
| RVVGKDLTVSGRILV | 91 | Q14657 | |
| IVLVGGSTRIPKVQR | 336 | P34931 | |
| LREGIIVTGKRLGTL | 296 | Q96PP9 | |
| RGTVVTGTLERGILK | 271 | P49411 | |
| SVGKLVTVRGIVTRV | 156 | P33993 | |
| GLLGVCIGEKRRIVV | 321 | O95302 | |
| AESGTRRGIPKVIVV | 1126 | Q05707 | |
| GVIKTIGTTVGRRRR | 101 | P15408 | |
| VLIGVQGTPVVRKGR | 16 | Q07325 | |
| VRSVCRGKGKILVGT | 1656 | Q05BV3 | |
| TEIVGSKQRRIVGIV | 231 | O75751 | |
| QTIIIGVRKGGTRAL | 56 | O14792 | |
| VGAAGRRLVKIAVVG | 26 | Q9BPW5 | |
| RRLVKIAVVGASGVG | 31 | Q9BPW5 | |
| RVPVGTLVKEGGRVV | 156 | Q9H4K7 | |
| RGKDGRIVNVTVIRG | 1076 | P08F94 | |
| GVRRLIGVTEIEKGS | 351 | Q9NRZ7 | |
| GVLGITKVGSRRVIQ | 446 | Q9UGH3 | |
| IGVLGITKVGSRRVV | 386 | Q9UHI7 | |
| VRVGGQESKVTVRGL | 2566 | P22105 | |
| KRGSDIIIVGRGIIS | 441 | P11172 | |
| GQKVKGTVRRVVLRG | 1776 | P27708 | |
| TAVGVRGRDIVVLGV | 31 | O14818 | |
| KVLRTSGARGTVIVP | 551 | P57103 | |
| RVIVGTIRPRVIVGS | 26 | P0DI83 |